CooperVision Q3 2026 net income rises to $432.8 million
Q3 2026 net income surged to $432.8 million, driven by a discrete tax benefit and insurance recoveries. Net sales were flat at $1,066.2 million, and the company increased share repurchase authorization after resolving major litigation.
2 million. CooperVision and CooperSurgical posted stable or modest growth, and the company resolved major litigation while increasing share repurchase authoriz…